Table 3.

List of some of the selected ongoing cancer vaccine clinical trials that are in phase II/III/IV stages. Data source ClinicalTrials.gov (www.clinicaltrials.gov, accessed on 25 June 2022).

Disease Condition	Drug Combination	Phase	Participants	Status	NCT Number
Breast cancer	AST-301[pNGVL3-hICD (DNA vaccine against HER2)], rhuGM-CSF, Pembrolizumab Adagloxad simolenin, OBI-821 (Vaccine with tumor-associated antigen Globo H linked to KLH).	II III	146 668	Recruiting Recruiting	NCT05163223 NCT03562637
Cervical cancer	Recombinant Human Papillomavirus Bivalent Vaccine, Recombinant Human Papillomavirus Nonavalent Vaccine, Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Cecolin® (bivalent HPV vaccine) Gardasil® (HPV 9-valent Vaccine) Gardasil-9 (9-valent HPV Vaccination)	IV III III	5000 1025 1220	Enrolling by invitation Active, not recruiting Not yet recruiting	NCT05237947 NCT04508309 NCT03848039
Colorectal cancer	GRT-C901, GRT-R902[Chimpanzee adenovirus vector (ChAdV)twenty tumor-specific neoantigens (TSNAs)], Atezolizumab, Ipilimumab, Fluoropyrimidine, Bevacizumab, Oxaliplatin	II/III	665	Recruiting	NCT05141721
Bladder cancer	Bacillus Calmette-Guérin (BCG) Bacillus Calmette Guerin (BCG), PF-06801591(anti-PD1 mAb)	III III	32 1160	Active not yet recruiting Recruiting	NCT04806178 NCT04165317
Liver cancer	GP96 (Heat Shock Protein-Peptide Complex Vaccine)	II/III	80	Not yet Recruiting	NCT04206254
Acute myeloid leukemia	DSP-7888 [vaccine with two synthetic peptides derived from Wilms’ tumor 1 (WT1)	II	100	Recruiting	NCT04747002
Non-small cell lung cancer	UCPVax [vaccine with two peptides from hTERT], Nivolumab	II	111	Recruiting	NCT04263051
Glioblastoma multiforme	ADCTA-SSI-G1 (Autologous Dendritic Cell/Tumor Antigen)	III	118	Recruiting	NCT04277221